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Background:  Propofol may decrease myocardial contractility via actions on the β-adrenoceptor-mediated signal 
transduction.  The aim of this study was to evaluate the effect of propofol via β-adrenoceptor-mediated signal 
transduction by measuring the tissue levels of cAMP (cyclic adenosine monophosphate).
Methods:  The effects of propofol on β-adrenoceptor mediated cascades were measured with cAMP concentrations, 
which were stimulated by agonists (l-isoproterenol, GTPγS, and forskolin) of each step of β-adrenoceptor-mediated 
cascades.
Results:  While the production of cAMP stimulated by isoproterenol, GTP γS, or forskolin are increased (P < 0.05), 
application of each concentration of propofol (0.1, 1, 10, 100 μM) did not alter the levels of cAMP. 
Conclusions:  Considering that propofol did not alter the tissue cAMP levels when stimulated by isoproterenol, 
GTPγS, and forskolin, propofol appears to have no effect on the β-adrenoceptor signaling pathway in guinea pig 
ventricular myocardium.  (Korean J Anesthesiol 2010; 58: 374-377)
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Introduction
    Propofol is a widely used intravenous anesthetic with advan-
tageous properties such as rapid induction and emergence. 
However, induction of anesthesia with propofol is often 
associated with a decrease in systemic arterial pressure.
    At supraclinical concentrations which may occur during 
rapid bolus injection, a direct inhibitory effect of propofol on 
myocardial contraction in normal cardiac tissues of guinea 
pig [1-3] and ferret [4] as well as human atrial muscle [5] has 
been reported. Contributing factors on myocardial depression 
by propofol such as decreased ICa (L-type Ca
2+ current) 
via sarcolemma [6-8] and decreased Ca
2+ uptake by the 
sarcoplasmic reticulum [9-11] have been proposed. Recently, 375 www.ekja.org
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propofol has been reported to have direct inhibitory effects 
on β-adrenoceptor signal transduction, which may cause 
contractile depression in cardiac muscle [12]. However, the 
cellular mechanism has not been well-defined. 
    β-adrenoceptor stimulated by l-isoproterenol binds to 
β-adrenergic receptor and produce an interaction between 
β-adrenergic receptor and Gs (stimulatory G-protein), 
which enhances adenylyl cyclase activity. Adenylyl cyclase 
is a membrane-bound enzyme that converts intracellular 
adenosine phosphate (ATP) to cAMP, a second messenger in the 
signal transduction system. cAMP activates cAMP-dependent 
protein kinase (A-kinase), resulting in phosphorylation of 
particular proteins. Increased cAMP prolongs the opening time 
of Ca
2+ channels, resulting in increased Ca
2+ entry and positive 
inotropic effect. Inhibitory effects on the signal transduction 
pathway may also result in negative inotropic effect. 
    Therefore, we evaluated the effect of propofol on tissue cAMP 
levels via β-adrenoceptor-mediated signal transduction using 
β-adrenoceptor agonist, G-protein stimulant, and adenylyl 
cyclase agonist. 
Materials and Methods
Myocardial membrane preparation and quantitative 
analysis 
    The heart was excised from male guinea pigs (250-300 g) 
anesthetized with sevoflurane at 3-4 vol% according to a pro-
cedure approved by the Institutional Animal Research Com-
mittee. Blood was evacuated and the hearts were kept in ice-
cold buffer (0.25 M sucrose, 5 mM Tris/HCl, 1 mM MgCl2; pH 
7.4) aerated with 100% O2. Atrium, aorta, and other extraneous 
tissues were removed. Two hearts were homogenized with five 
volumes of ice-cold buffer, transferred into a 15 ml conical tube, 
and centrifuged at 600 g for 10 minutes at 4
oC. The supernatant 
was divided into six to eight 1.5 ml microcentrifuge tubes, and 
centrifuged at 15,000 g for 10 minutes at 4
oC. The supernatant 
was centrifuged again at 100,000 g for 60 minutes at 4
oC. The 
membrane pellet was dissolved in 1 ml of ice-cold incubation 
buffer (mM: 50 Tris/HCl, 10 MgCl2; pH 7.5) and used for quanti-
tative analysis. Quantitative analysis was performed with Bio-
chronic Acid Assay (BCA) kit (Pierce, Rockford, IL, USA). Pro-
tein concentration was measured by the method of Lowry [13], 
using a bovine serum albumin (0, 0.25, 0.5, 0.75, 1.0 mg/ml). 
About 3-4 mg/ml of membranous protein was achieved and 
kept at -20
oC after freezing with liquid nitrogen. 
Measurement of cAMP concentration 
    Each of 0.1, 1, 10, and 100 μM propofol, l-isoproterenol (0.1 
μM) or forskolin (3 μM) or GTPγS [guanosine 5”-O-(3-thio-
triphosphate)] (1 μM) and the membranous protein (250 μg) 
were added to cAMP production buffer (mM: 2.5 Na2ATP, 5 
MgCl2, 1 Tris-EGTA, 20 creatine phosphate, 50 U/ml creatine 
phosphokinase, 0.8 IBMX, 50 Tris/HCl, pH 7.5) in a total volume 
of 500 μl. In the preliminary experiments, we determined 
the concentrations of these three stimulants which showed 
maximum tissue levels of cAMP.
    To exclude the effect of DMSO on cAMP levels, the concen-
trations of DMSO used for forskolin were tested. After 10-min 
incubation at 37
oC, the reaction was stopped with 100
oC heat, 
and the sample was centrifuged at 6,000 g for 20 minutes at 
4
oC. The cAMP concentration in the supernatant was measured 
using a cAMP assay kit [cAMP Biotrak Enzymeimmunoassay 
(EIA) System, Amersham, UK].
    Working standard was prepared using the standard for acety-
lation assay, anti-serum, cAMP peroxidase conjugate and wash 
buffer provided by cAMP assay kit. Samples were diluted 100 
times in assay buffer [0.05 M sodium acetate (pH 5.8), 0.02% 
bovine serum albumin, 0.01% preservative]. Acetylation reagent 
mixed with two volumes of triethylamine and one volume of 
acetic anhydride was added to all standards (0-128 fmol) and 
samples. One hundred μl of cAMP antiserum was added to 96 
well plates coated with secondary antibody (except blank and 
non-specific binding wells), and 50 µl of samples or acetylation 
standard were added to each well. Assay buffer alone (150 μl) 
was added to non-specific binding wells. Plates were incubated 
for 60 minutes at 4
oC. cAMP peroxidase conjugate (100 μl) was 
added to all wells except blanks and plates were incubated for 
60 minutes at 4
oC. Wells were aspirated and washed 4 times 
with 400 μl wash buffer and TMB substrate (150 μl) was added. 
After 1-hour shaking at room temperature, the reaction was 
stopped with 1 M sulfuric acid (100 μl). cAMP concentration 
was measured at 450 nm with a spectrophotometer (ELISA 
Reader, Versamax, Molecular Devices, Union City, CA, USA). 
The experiment was performed in duplicate.
Statistical analysis
    One-way ANOVA followed by the Student-Newman-Keuls test 
was applied to test for the significant differences among control 
and drug applications. All values were expressed as mean ± SD. 
A P value less than 0.05 was considered significant. 
Results
    Whereas tissue cAMP levels produced by isoproterenol (0.1 μM), 
GTP γS (1 μM), and forskolin (3 μM) in guinea pig myocardium 
were increased when compared to baseline values before 
treatment of each stimulant, application of propofol (0.1, 1, 376 www.ekja.org
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10, and 100 μM) did not alter the tissue cAMP levels when 
stimulated by isoproterenol (n = 10), GTPγS (n = 6), and 
forskolin (n = 6) (Table 1) (NS).
    DMSO (3 μM) did not produce any change in the tissue cAMP 
levels (n = 8, NS) (control: 489 ± 183 fmol/mg protein).
Discussion
    This study shows that either clinically relevant or supraclinical 
concentrations of propofol have no effect on the tissue cAMP 
levels evoked by β-adrenoceptor stimulation (l-isoproterenol), 
G-protein stimulation (GTPγS), and adenylyl cyclase stimu-
lation (forskolin). 
    In vitro studies using normal cardiac tissue have reported 
that propofol has negative inotropic effect in guinea pig [1-3] 
and ferret [4] ventricular myocardium as well as in human 
atrial muscles [5] at supraclinical concentrations. However, at 
clinically relevant concentrations, most in vitro studies indicate 
that propofol exerts little negative inotropic effect [1,9,10]. At 
supraclinical concentrations, myocardial depression by pro-
pofol has been attributed to decreased ICa via sarcolemma [6-8] 
and decreased Ca
2+ uptake by the sarcoplasmic reticulum [9-11]. 
However, clinically relevant doses of propofol (0.1-10 μM) had no 
significant effect on steady state ICa [14]. Clinical concentrations 
after induction with propofol range from 2 μg/ml (11.2 μM) 
to 15 μg/ml (84 μM) [15]. Considering that protein binding of 
propofol exceeds 95%, free fractions of propofol are less than 1 
μg/ml (5.6 μM).
    Zhou et al. [12] in their study using rat ventricular myocar-
dium demonstrated that relatively high concentrations of 
propofol (25-200 μM) antagonized β-adrenoceptor binding. 
Although these results suggest direct inhibitory effects of 
propofol on β-adrenoceptor signal transduction, the mecha-
nism at the cellular level has not been well elucidated. In rat 
cardiomyocytes, Kurokawa et al. [14] demonstrated that clini-
cally relevant concentrations of propofol (0.1-10 μM) had no 
significant effect on steady state ICa but attenuated the increased 
ICa induced by isoproterenol. In their cAMP experiments, 
whereas propofol attenuated the isoproterenol-induced 
increase in cAMP production, propofol did not alter the increase 
in cAMP induced by direct activation of adenylyl cyclase with 
forskolin. Therefore, they proposed that the inhibitory site of 
action of propofol is upstream of adenylyl cyclase. These results 
indicate that propofol-induced depression of the isoproterenol-
stimulated increase in [Ca
2+]i and shortening of cardiomyocytes 
are mediated by a decrease in ICa, which suggest that propofol 
interferes with the β-adrenergic pathway. In contrast, in guinea 
pig ventricular tissues, we did not observe any attenuation of 
increased tissue cAMP levels induced by isoproterenol at either 
clinically relevant or supraclinical concentrations of propofol. 
The inhibitory potency of propofol in myocardial contractility 
at supraclinical concentrations has been reported in guinea 
pig ventricular papillary muscles [1,3,4]. In contrast, propofol, 
at either clinically relevant or supraclinical concentrations, 
was devoid of substantial negative inotropic action in rat 
papillary muscle [1,9]. Whereas Azuma et al. [1], in their study 
using rat and guinea pig ventricular myocardium, observed 
that supraclinical concentrations of propofol (600 μM) caused 
modest shortening of action potential duration, significant 
shortening was shown in guinea pig preparations, which 
suggests species difference in sensitivity of ICa to propofol. 
Considering these different results, species difference may 
account for the discrepancies observed in the tissue levels of 
cAMP. 
    In conclusion, considering that propofol did not alter the 
tissue cAMP levels when stimulated by isoproterenol, GTPγS, 
and forskolin, propofol appears to have no effect on the β -adren-
oceptor signaling pathway in guinea pig ventricular myo  car  dium.
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